The effects of soybean-derived phospholipid, PIPS NAGASE(TM) (PIPS), on obesity-induced diseases were studied in obese rats. Dietary PIPS alleviated hepatomegaly and fatty liver in the rats. These effects were attributable to reduced lipogenesis and enhanced lipolysis in the liver. The results suggest that PIPS can be useful as a dietary component that would reduce the risk of lifestyle-related diseases.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1271/bbb.100408 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!